~~<i id='918FBA237C'><strike id='918FBA237C'><tt id='918FBA237C'><pre id='918FBA237C'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

Wikipedia

author：explore 2025-09-30 23:06:19 - browse：32759

Bruce Broussard. -- health business coverage from STAT — Humana CEO Bruce Broussard Jason DeCrow/AP

Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading the company for more than a decade.

Humana named Jim Rechtin — who is the CEO of Envision Healthcare, the controversial physician staffing firm that is working its way through bankruptcy — as Broussard’s replacement. Rechtin will serve as president and chief operating officer starting Jan. 8 and then take over as CEO in the “latter half of 2024,” the company said in a news release.

Humana’s stock fell by more than 2% on the news Wednesday morning.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： FDA has safety concerns on CRISPR

Wikipedia

entertainment

hotspot

PacketsofbuprenorphineEliseAmendola/APDoctorsarereportingatroublingtrendwhenitcomestofentanyl.Thepow

WSS

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Eli Lilly to pay $200M for Beam’s stake in gene

Eyeing GLP

explore

Wikipedia

Wikipedia

Moonlake's readout produced a cash windfall. Risks remain

Making the case for fair compensation in clinical trials

Peter Hotez and the public health issue of online harassment

First Opinion Podcast: How to protect health care in times of war

Novavax promises a turnaround & Lilly roils the obesity market

Medtronic CEO on promising devices for diabetes, hypertension

Moonlake's readout produced a cash windfall. Risks remain

Why Sanofi got shellacked over its spinoff

Heart attack and stroke risk calculators need revising

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Wikipedia

For longer

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Making the case for fair compensation in clinical trials

Physician subsidies by hospitals soar in wake of No Surprises Act

H5N1 virus can be tracked in retail milk, scientists say

Study finds gene variants tied to breast cancer risk in Black women

entertainment

hotspot

hotspot

hotspot